{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:39:37Z","timestamp":1792507177052,"version":"4.5.0"},"update-to":[{"DOI":"10.1371\/journal.pntd.0012973","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000}}],"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"U.S. Department of Homeland Security Science and Technology Directorate","award":["HSHQDC-15-C-00064"],"award-info":[{"award-number":["HSHQDC-15-C-00064"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p><jats:italic>Bacillus anthracis<\/jats:italic> is a zoonotic organism that causes the disease anthrax due to the activity of virulence factors harbored on plasmids pXO1 and pXO2. Inhalation of <jats:italic>B. anthracis<\/jats:italic> spores results in pneumonic disease that progresses quickly, and often results in lethality in the absence of medical countermeasure (MCM) intervention. Recently, reports have identified <jats:italic>Bacillus cereus<\/jats:italic> isolates that possess pXO1 and pXO2-like plasmids and cause an anthrax-like disease. These isolates have been named <jats:italic>B. cereus<\/jats:italic> biovar <jats:italic>anthracis<\/jats:italic>, or Bcbva. To evaluate disease course of Bcbva, the inhalational median lethal dose (INHLD<jats:sub>50<\/jats:sub>) was determined for two isolates, Bcbva Cameroon (CA) and Bcbva Cote d\u2019Ivoire (CI), using the New Zealand white (NZW) rabbit inhalation anthrax model and compared to established <jats:italic>B. anthracis<\/jats:italic> inhalation data. Furthermore, disease progression and anthrax MCM efficacies were evaluated by quantifying temperature responses, bacteremia, and virulence factor production in both survivor and non-survivor animals. This study determined that the rabbit INHLD<jats:sub>50<\/jats:sub> values for Bcbva CA and CI were similar to that published for <jats:italic>B. anthracis<\/jats:italic> Ames. The mean time to significant increase in body temperature (SIBT) and death were dose dependent for both Bcbva isolates, and all animals that succumbed to aerosol exposure displayed SIBT prior to death. Serum hyaluronic acid concentration increased prior to mortality in animals challenged with Bcbva and differences were observed in serum protective antigen concentration in animals challenged with Bcbva compared to <jats:italic>B. anthracis<\/jats:italic>. Pre-exposure vaccination with Anthrax Vaccine Adsorbed (AVA) and post-exposure prophylaxis of levofloxacin with or without AVA vaccination were effective against a challenge of ~200 INHLD<jats:sub>50<\/jats:sub> of Bcbva CA or CI. Collectively, these data suggest that anthrax-like disease caused by Bcbva is similar to that caused by <jats:italic>B. anthracis<\/jats:italic> Ames 2084, and that currently available countermeasures are effective against inhalation exposure to Bcbva.<\/jats:p>","DOI":"10.1371\/journal.pntd.0012973","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T21:32:56Z","timestamp":1744061576000},"page":"e0012973","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bacillus cereus biovar anthracis causes inhalational anthrax-like disease in rabbits that is treatable with medical countermeasures"],"prefix":"10.1371","volume":"19","author":[{"given":"Allison M.","family":"Ferris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea B.","family":"Eyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Yeager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan K.","family":"Bohannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy A.","family":"Boydston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa L.","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Balzli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6588-4308","authenticated-orcid":true,"given":"Victoria","family":"Wahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy D.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry L.","family":"Rippeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Manan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley F.","family":"Harman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim R.","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina M.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather D.","family":"Cronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron L.","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Winpigler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec S.","family":"Hail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4123-8229","authenticated-orcid":true,"given":"Angelo","family":"Scorpio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"issue":"11","key":"pntd.0012973.ref001","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199909093411107","article-title":"Anthrax","volume":"341","author":"T Dixon","year":"1999","journal-title":"N Engl J Med"},{"issue":"12","key":"pntd.0012973.ref002","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.2741\/3544","article-title":"Pathophysiology of anthrax","volume":"14","author":"AE Frankel","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"3","key":"pntd.0012973.ref003","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1462-5822.2006.00866.x","article-title":"Contribution of toxins to the pathogenesis of inhalational anthrax","volume":"9","author":"J Tournier","year":"2007","journal-title":"Cell Microbiol"},{"key":"pntd.0012973.ref004","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev.micro.55.1.647","article-title":"Anthrax","volume":"55","author":"M Mock","year":"2001","journal-title":"Ann Rev Microbiol"},{"issue":"5","key":"pntd.0012973.ref005","doi-asserted-by":"crossref","first-page":"e01501-16","DOI":"10.1128\/mBio.01501-16","article-title":"A bacillus anthracis genome sequence from the sverdlovsk 1979 autopsy specimens","volume":"7","author":"JW Sahl","year":"2016","journal-title":"mBio"},{"issue":"1\u20133","key":"pntd.0012973.ref006","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0168-1656(95)00092-5","article-title":"Development of novel vaccines against anthrax in man","volume":"44","author":"AV Stepanov","year":"1996","journal-title":"J Biotechnol"},{"key":"pntd.0012973.ref007","first-page":"335","article-title":"Anthrax: clinical features, pathogenesis, and potential biological warfare threat","volume":"20","author":"AM Friedlander","year":"2000","journal-title":"Curr Clin Top Infect Dis"},{"issue":"6","key":"pntd.0012973.ref008","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.mam.2009.08.005","article-title":"The genome and variation of Bacillus anthracis","volume":"30","author":"P Keim","year":"2009","journal-title":"Mol Aspects Med"},{"issue":"10","key":"pntd.0012973.ref009","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1128\/JB.182.10.2928-2936.2000","article-title":"Multiple-locus variable-number tandem repeat analysis reveals genetic relationships within Bacillus anthracis","volume":"182","author":"P Keim","year":"2000","journal-title":"J Bacteriol"},{"issue":"6","key":"pntd.0012973.ref010","doi-asserted-by":"crossref","first-page":"e0156987","DOI":"10.1371\/journal.pone.0156987","article-title":"Anthrax Toxin-Expressing Bacillus cereus Isolated from an Anthrax-Like Eschar","volume":"11","author":"CK Marston","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"pntd.0012973.ref011","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1128\/JB.181.8.2358-2362.1999","article-title":"Genetic diversity in the protective antigen gene of Bacillus anthracis","volume":"181","author":"LB Price","year":"1999","journal-title":"J Bacteriol"},{"issue":"5","key":"pntd.0012973.ref012","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.1371\/journal.pone.0000461","article-title":"Global genetic population structure of Bacillus anthracis","volume":"2","author":"MN Van Ert","year":"2007","journal-title":"PLoS One"},{"key":"pntd.0012973.ref013","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1186\/s12864-016-2883-z","article-title":"Production of hemolysin BL by Bacillus cereus group isolates of dairy origin is associated with whole-genome phylogenetic clade","volume":"17","author":"J Kovac","year":"2016","journal-title":"BMC Genomics"},{"issue":"8","key":"pntd.0012973.ref014","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1128\/IAI.00205-11","article-title":"Bacillus cereus G9241 makes anthrax toxin and capsule like highly virulent B. anthracis Ames but behaves like attenuated toxigenic nonencapsulated B. anthracis Sterne in rabbits and mice","volume":"79","author":"MK Wilson","year":"2011","journal-title":"Infect Immun"},{"issue":"15","key":"pntd.0012973.ref015","doi-asserted-by":"crossref","first-page":"5333","DOI":"10.1128\/JB.00303-06","article-title":"Characterization of Bacillus anthracis-like bacteria isolated from wild great apes from Cote d\u2019Ivoire and Cameroon","volume":"188","author":"SR Klee","year":"2006","journal-title":"J Bacteriology"},{"issue":"9","key":"pntd.0012973.ref016","doi-asserted-by":"crossref","first-page":"e0004923","DOI":"10.1371\/journal.pntd.0004923","article-title":"Bacillus cereus Biovar anthracis causing anthrax in sub-saharan africa-chromosomal monophyly and broad geographic distribution","volume":"10","author":"KS Antonation","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"pntd.0012973.ref017","doi-asserted-by":"crossref","first-page":"e0003455","DOI":"10.1371\/journal.pntd.0003455","article-title":"Capsules, toxins and AtxA as virulence factors of emerging Bacillus cereus biovar anthracis","volume":"9","author":"C Br\u00e9zillon","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"pntd.0012973.ref018","doi-asserted-by":"crossref","first-page":"e10986","DOI":"10.1371\/journal.pone.0010986","article-title":"The genome of a Bacillus isolate causing anthrax in chimpanzees combines chromosomal properties of B. cereus with B. anthracis virulence plasmids","volume":"5","author":"SR Klee","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"pntd.0012973.ref019","doi-asserted-by":"crossref","first-page":"e0003746","DOI":"10.1371\/journal.pntd.0003746","article-title":"Correction: Capsules, toxins and AtxA as virulence factors of emerging Bacillus cereus biovar anthracis","volume":"9","author":"Staff PLOS Neglected Tropical Diseases","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"pntd.0012973.ref020","doi-asserted-by":"crossref","first-page":"e0008292","DOI":"10.1371\/journal.pntd.0008292","article-title":"Serological evidence for human exposure to Bacillus cereus biovar anthracis in the villages around Ta\u00ef National Park, C\u00f4te d\u2019Ivoire","volume":"14","author":"S Dupke","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"pntd.0012973.ref021","doi-asserted-by":"crossref","first-page":"e0005960","DOI":"10.1371\/journal.pntd.0005960","article-title":"Low antibody prevalence against Bacillus cereus biovar anthracis in Ta\u00ef National Park, C\u00f4te d\u2019Ivoire, indicates high rate of lethal infections in wildlife","volume":"11","author":"F Zimmermann","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"178","key":"pntd.0012973.ref022","first-page":"63138","article-title":"Possession, Use, and Transfer of Select Agents and Toxins-- Addition of Bacillus Cereus Biovar Anthracis to the HHS List of Select Agents and Toxins. Interim final rule and request for comments","volume":"81","author":"Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS)","year":"2016","journal-title":"Fed Regist"},{"issue":"2","key":"pntd.0012973.ref023","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/IAI.70.2.661-664.2002","article-title":"Anthrax spores make an essential contribution to vaccine efficacy","volume":"70","author":"F Brossier","year":"2002","journal-title":"Infect Immun"},{"issue":"10","key":"pntd.0012973.ref024","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1016\/S0021-9258(18)62213-6","article-title":"The stability of messenger ribonucleic acid during sporulation in Bacillus subtilis","volume":"246","author":"TJ Leighton","year":"1971","journal-title":"J Biol Chem"},{"issue":"6","key":"pntd.0012973.ref025","first-page":"792","article-title":"Using telemetry data to refine endpoints for new zealand white rabbits challenged with bacillus anthracis","volume":"56","author":"DG Dawson","year":"2017","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"pntd.0012973.ref026","unstructured":"Bide R, Armour S, Yee E. Estimation of human toxicity from animal inhalation toxicity data: Minute volume-body weight relationships between animals and man. 1997."},{"issue":"4","key":"pntd.0012973.ref027","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/1099-1263(200007\/08)20:4<273::AID-JAT657>3.0.CO;2-X","article-title":"Allometric respiration\/body mass data for animals to be used for estimates of inhalation toxicity to young adult humans","volume":"20","author":"RW Bide","year":"2000","journal-title":"J Appl Toxicol"},{"key":"pntd.0012973.ref028","volume-title":"Encapsulation of Bacillus anthracis spores and spore identification","author":"J Ezzell","year":"1999"},{"issue":"11","key":"pntd.0012973.ref029","first-page":"982","article-title":"The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation","volume":"122","author":"G Zaucha","journal-title":"Arch Pathol Lab Med1998"},{"issue":"11","key":"pntd.0012973.ref030","article-title":"Physiological Responses to Multiple Low-Doses of Bacillus anthracis Spores in the Rabbit Model of Inhalation Anthrax","volume":"9","author":"SC Taft","journal-title":"Pathogens2020"},{"issue":"9","key":"pntd.0012973.ref031","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1128\/CVI.00292-12","article-title":"Characterization of a therapeutic model of inhalational anthrax using an increase in body temperature in New Zealand white rabbits as a trigger for treatment","volume":"19","author":"JE Comer","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"10","key":"pntd.0012973.ref032","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1128\/IAI.00792-06","article-title":"Protective antigen as a correlative marker for anthrax in animal models","volume":"74","author":"D Kobiler","year":"2006","journal-title":"Infect Immun"},{"issue":"1","key":"pntd.0012973.ref033","doi-asserted-by":"crossref","first-page":"e84947","DOI":"10.1371\/journal.pone.0084947","article-title":"Toxin-independent virulence of Bacillus anthracis in rabbits","volume":"9","author":"H Levy","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"pntd.0012973.ref034","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/IAI.01875-06","article-title":"Murine aerosol challenge model of anthrax","volume":"75","author":"C Loving","year":"2007","journal-title":"Infect Immunity"},{"issue":"6","key":"pntd.0012973.ref035","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9060461","article-title":"Physiological responses to a single low-dose of Bacillus anthracis spores in the rabbit model of inhalational anthrax","volume":"9","author":"S Taft","year":"n.d","journal-title":"Pathogens"},{"issue":"1","key":"pntd.0012973.ref036","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/jam.14114","article-title":"Analysis of a newly discovered antigen of Bacillus cereus biovar anthracis for its suitability in specific serological antibody testing","volume":"126","author":"S Dupke","year":"2019","journal-title":"J Appl Microbiol"},{"issue":"4","key":"pntd.0012973.ref037","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1128\/AAC.01050-06","article-title":"Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model","volume":"51","author":"HS Heine","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"pntd.0012973.ref038","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/0264-410X(94)90027-2","article-title":"Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea-pigs","volume":"12","author":"BE Ivins","year":"1994","journal-title":"Vaccine"},{"issue":"1","key":"pntd.0012973.ref039","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1128\/IAI.74.1.794-797.2006","article-title":"Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen","volume":"74","author":"KK Peachman","year":"2006","journal-title":"Infect Immun"},{"issue":"11","key":"pntd.0012973.ref040","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1128\/IAI.70.11.6231-6241.2002","article-title":"Postexposure prophylaxis against anthrax: evaluation of various treatment regimens in intranasally infected guinea pigs","volume":"70","author":"Z Altboum","year":"2002","journal-title":"Infect Immun"},{"issue":"23\u201324","key":"pntd.0012973.ref041","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/S0264-410X(01)00021-4","article-title":"Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin","volume":"19","author":"PF Fellows","year":"2001","journal-title":"Vaccine"},{"issue":"10","key":"pntd.0012973.ref042","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.vaccine.2020.01.068","article-title":"Development of a guinea pig inhalational anthrax model for evaluation of post-exposure prophylaxis efficacy of anthrax vaccines","volume":"38","author":"MR Perry","year":"2020","journal-title":"Vaccine"},{"issue":"4","key":"pntd.0012973.ref043","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1128\/AAC.01689-10","article-title":"Antibiotics cure anthrax in animal models","volume":"55","author":"S Weiss","year":"2011","journal-title":"Antimicrob Agents Chemother"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0012973","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0012973","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T17:51:20Z","timestamp":1744912280000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0012973"}},"subtitle":[],"editor":[{"given":"Adly M.M.","family":"Abd-Alla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0012973","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0012973","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]}}}